JWCA
QNTM

J.W. Cole Advisors’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

J.W. Cole Advisors’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,590
Closed -$97.1K – 1493
2025
Q1 		$97.1K Buy
+12,590
New +$72.4K ﹤0.01% 1207

Other funds holding QNTM

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CTC
Cetera Trust Company St. Paul, Minnesota $177M AUM 28.75% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

J.W. Cole Advisors's QNTM Position: Q2 2025 in Review

J.W. Cole Advisors sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q2 2025, closing a stake of 12,590 shares — an estimated $97.1K sold.

J.W. Cole Advisors first reported a position in QNTM in Q1 2025 and held it in 1 quarter. The position peaked at $97.1K in Q1 2025. 17 funds tracked by Wall St. Rank hold QNTM as of Q2 2025.

  • J.W. Cole Advisors reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q2 2025 after selling out during the quarter.
  • J.W. Cole Advisors sold 12,590 Quantum Biopharma Class B Subordinate Voting Shares shares in Q2 2025, an estimated $97.1K.
  • J.W. Cole Advisors first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2025 and held it in 1 quarter.
  • J.W. Cole Advisors's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $97.1K in Q1 2025.
  • 17 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2025.

Based on J.W. Cole Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.